Journal · Updated 2026-08-11
Tirzepatide 15 mg: The Maximum Dose — the 20.9% Arm and the Questions at the Top
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
The maximum dose's numbers are the class's flagship: 20.9% average body-weight loss at 72 weeks in SURMOUNT-1's 15 mg arm — roughly a fifth of body weight, the result that reset expectations for obesity pharmacotherapy — achieved with the ladder's highest rates of GI side effects and discontinuation, which is the honest pairing every maximum carries. Practical realities at the top: the escalation that got here took a minimum of twenty weeks by label spacing; the brand price finished climbing two rungs ago ($449 covers 7.5–15); dose-flat compounded programs charge the same $169–$179 they always did — the structural argument they exist to make; and a plateau here meets the ladder's hard truth: there is no 17.5, so the next moves are the non-dose levers, time, or the clinical conversation about goals.
Life at the maximum
Three top-rung specifics. Tolerability is the tax: the 15 mg arm's side-effect and dropout rates ran highest, and a patient who reaches max but lives poorly there has the label's full permission to step back — 12.5 or 10 mg with durable adherence beats 15 with misery, and the 1.4-point average gap says the cost is small. The plateau question changes character: with no higher dose to reach for, a stall at 15 routes entirely through the checklist (protein, training, sleep, logging honesty, medical rule-outs) and through expectation-setting — the trial's 20.9% was an average at 72 weeks, individual curves flatten at different totals, and a settled body at minus-eighteen percent is a success, not a malfunction. Maintenance at max is normal: many long-term patients hold 15 mg indefinitely per the withdrawal data's logic — the dose that achieved the result is often the dose that keeps it, and down-titration experiments are prescriber-guided, one rung at a time, with the scale as referee. Mechanics: 1.5 mL at 10 mg/mL (150 units — often two draws or a higher-concentration vial, which is exactly when the units math gets re-done from the label), ≥4-day window, and the surgery hold unchanged.
Questions people ask
How much weight will I lose on tirzepatide 15 mg?
The SURMOUNT-1 15 mg arm averaged 20.9% body-weight loss at 72 weeks — the strongest studied result in the approved class — with the ladder's highest side-effect and discontinuation rates. Individual results vary widely around that average, and stepping back for tolerability is label-sanctioned.
How do I measure 15 mg of compounded tirzepatide?
Concentration decides everything: at 10 mg/mL, 15 mg = 1.50 mL (150 units on a U-100 syringe); at 17 mg/mL the numbers change entirely. Read your vial's mg/mL, do the math from our units guide, and redo it on every new vial — concentration changes between batches are how the overdose reports happen.
What does the 15 mg dose cost?
Compounded: dose-flat programs charge the same at every dose — $169–$179/month in the credible tier. Brand: Zepbound vials price by rung ($299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg up, 45-day rule attached). Insurance, where it covers, prices by copay regardless of milligrams.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.